ATE243684T1 - Kristalle eines oximinoalkansäure-derivates und ihre verwendung als antidiabetika - Google Patents

Kristalle eines oximinoalkansäure-derivates und ihre verwendung als antidiabetika

Info

Publication number
ATE243684T1
ATE243684T1 AT00970081T AT00970081T ATE243684T1 AT E243684 T1 ATE243684 T1 AT E243684T1 AT 00970081 T AT00970081 T AT 00970081T AT 00970081 T AT00970081 T AT 00970081T AT E243684 T1 ATE243684 T1 AT E243684T1
Authority
AT
Austria
Prior art keywords
oximinoalkanic
crystals
acid derivative
antidiabetic drugs
antidiabetic
Prior art date
Application number
AT00970081T
Other languages
English (en)
Inventor
Yu Momose
Hiroshi Imoto
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ATE243684T1 publication Critical patent/ATE243684T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT00970081T 1999-10-29 2000-10-26 Kristalle eines oximinoalkansäure-derivates und ihre verwendung als antidiabetika ATE243684T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP30834699 1999-10-29
PCT/JP2000/007482 WO2001032637A1 (en) 1999-10-29 2000-10-26 Crystals of an oxyiminoalkanoic acid derivative and their use as antidiabetics

Publications (1)

Publication Number Publication Date
ATE243684T1 true ATE243684T1 (de) 2003-07-15

Family

ID=17979966

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00970081T ATE243684T1 (de) 1999-10-29 2000-10-26 Kristalle eines oximinoalkansäure-derivates und ihre verwendung als antidiabetika

Country Status (18)

Country Link
US (1) US6777435B1 (de)
EP (1) EP1224178B1 (de)
KR (1) KR100433885B1 (de)
CN (1) CN1407975A (de)
AR (1) AR031078A1 (de)
AT (1) ATE243684T1 (de)
AU (1) AU7958100A (de)
CA (1) CA2388200A1 (de)
CL (1) CL2000002938A1 (de)
CO (1) CO5261530A1 (de)
DE (1) DE60003577T2 (de)
HU (1) HUP0203884A3 (de)
MY (1) MY135840A (de)
NO (1) NO20022007L (de)
PE (1) PE20010761A1 (de)
PL (1) PL364171A1 (de)
TW (1) TW558554B (de)
WO (1) WO2001032637A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001072695A1 (en) * 2000-03-28 2001-10-04 Takeda Chemical Industries, Ltd. Neovascularization inhibitors
CA2442917C (en) 2001-04-04 2011-02-01 Ortho-Mcneil Pharmaceutical, Inc. Combination therapy comprising glucose reabsorption inhibitors and ppar modulators
EP1392326B1 (de) * 2001-04-04 2009-09-09 Ortho-McNeil-Janssen Pharmaceuticals, Inc. Kombinationstherapie durch glukoseresorptionshemmer und retinoid x rezeptorenmodulatoren
JP4399251B2 (ja) * 2001-05-30 2010-01-13 キッセイ薬品工業株式会社 グルコピラノシルオキシピラゾール誘導体、それを含有する医薬組成物、その医薬用途およびその製造中間体
TWI327462B (en) * 2002-01-18 2010-07-21 Sumitomo Chemical Co Condensed heterocyclic sulfonyl urea compound, a herbicide containing the same, and a method for weed control using the same
EP1508340A4 (de) * 2002-05-24 2009-07-01 Takeda Pharmaceutical Mittel zur verbesserung der insulinresistenz
US9132135B2 (en) * 2004-09-24 2015-09-15 University Of Maryland, Baltimore Method of treating organophosphorous poisoning
ES2519690T3 (es) * 2004-09-24 2014-11-07 University Of Maryland, Baltimore Método de tratamiento de envenenamiento por organosfósforo
JP2009507050A (ja) * 2005-09-08 2009-02-19 ガストロテック・ファルマ・アクティーゼルスカブ 胆道ジスキネジーおよび／または胆道痛／不快の治療のためのｇｌｐ−１分子の使用
TW201138843A (en) 2009-12-18 2011-11-16 Colgate Palmolive Co Biguanide preservation of precipitated calcium carbonate
WO2015109231A1 (en) * 2014-01-17 2015-07-23 Cornell University Methods of treating metabolic syndrome related conditions using retinoic acid receptor agonists
US11191755B2 (en) 2014-01-17 2021-12-07 Cornell University Compositions and methods for providing cardioprotective effects
WO2018002673A1 (en) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Novel formulations of angiotensin ii receptor antagonists
KR102281228B1 (ko) 2019-09-03 2021-07-22 신창수 과수나무의 가지지지용 파이프클램프

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6251926B1 (en) * 1998-05-11 2001-06-26 Takeda Chemical Industries, Ltd. Oxyiminoalkanoic acid derivatives with hypoglycemic and hypolipidemic activity
KR20020051925A (ko) * 1999-10-29 2002-06-29 다케다 야쿠힌 고교 가부시키가이샤 옥시이미노알카노산 유도체의 제조 방법

Also Published As

Publication number Publication date
CN1407975A (zh) 2003-04-02
NO20022007D0 (no) 2002-04-26
EP1224178A1 (de) 2002-07-24
NO20022007L (no) 2002-06-24
HK1044536A1 (en) 2002-10-25
KR100433885B1 (ko) 2004-06-04
DE60003577T2 (de) 2004-04-29
CO5261530A1 (es) 2003-03-31
PE20010761A1 (es) 2001-08-01
EP1224178B1 (de) 2003-06-25
CL2000002938A1 (es) 2009-05-15
CA2388200A1 (en) 2001-05-21
AR031078A1 (es) 2003-09-10
AU7958100A (en) 2001-05-14
TW558554B (en) 2003-10-21
HUP0203884A3 (en) 2005-01-28
MY135840A (en) 2008-07-31
US6777435B1 (en) 2004-08-17
DE60003577D1 (de) 2003-07-31
HUP0203884A2 (hu) 2003-03-28
WO2001032637A1 (en) 2001-05-10
PL364171A1 (en) 2004-12-13
KR20010102429A (ko) 2001-11-15

Similar Documents

Publication Publication Date Title
DE60039539D1 (de) 4-aminopiperidin-derivate und ihre verwendung als arzneimittel
ATE299503T1 (de) Pyridin-3-carbonsäurederivate und ihre verwendung als zwischenprodukte
ATE243684T1 (de) Kristalle eines oximinoalkansäure-derivates und ihre verwendung als antidiabetika
DE60123461D1 (de) Salze eines 4-isothiazolcarboxamids und ihre verwendung als anti-hyperproliferationsmittel
NO20022600L (no) Nye heterocykliske forbindelser og salter derav og medisinsk anvendelse av samme
DE50008597D1 (de) Thiazolylharnstoff-derivate und ihre verwendung als antivirale mittel
ATE277895T1 (de) 4-brom or 4-iod-phenylamino- benzhydroxamsäurederivate und ihre anwendung als mek-inhibitoren
ATE316080T1 (de) Sulfonylderivate von aminosäuren und deren verwendung als inhibitoren der dipeptidyl- peptidase iv (dpp iv)
DE69840519D1 (de) Heteroaryl-hexansäureamid-derivate, ihre herstellung und ihre verwendung als selektive inhibitoren der bindung von mip-1-alpha an seinen ccr1 rezeptor
DE60141603D1 (de) Neue mandelsäurederivate und deren verwendung als thrombininhibitoren
ATE340160T1 (de) Picolinsäure-derivate und ihre verwendung als fungizide
DE60017376D1 (de) Carbaminsäurederivate und ihre verwendung als liganden von metabotropen glutamatrezeptoren
ATE394102T1 (de) Substituierte chinazolin-derivate und deren verwendung als aurora-2-kinase inhibitoren
ATE344791T1 (de) 2-(4-brom or 4-iod phenylamino)benzoesäurederivate und ihre anwendung als mek-inhibitoren
DE60118155D1 (de) 3-phenoxy-1-phenyl acetylenderivate und ihre verwendung als herbizide
ATE247653T1 (de) Thiazolidindionderivat und seine verwendung als antidiabetikum
IS5582A (is) Meta-asahringamínóbensósýrusambönd og afleiður þeirra reynast mótlyf við integríni.
ATE218534T1 (de) Substituierte aminoverbindungen und ihre verwendung als analgetisch wirksame substanzen
DE50206476D1 (de) Cyanoanthranylamid-derivate und deren verwendung als arzneimittel
ATE247109T1 (de) Substituierte benzoylisoxazole und ihre verwendung als herbizide
DE69610316D1 (de) Piperazin-derivate und ihre verwendung als 5-ht1a-antagoniste
DE60037183D1 (de) Neue amidinbenzylamin-derivate und ihre verwendung als thrombin-inhibitoren
DE69510228D1 (de) Piperidinessigsäurederivate und ihre verwendung als fibrinogenantagonistmittel
DE50305374D1 (de) Neue prodrugs von 1-methyl-2-(4-amidinophenylaminomethyl)-benzimidazol-5-yl-carbonsäure-(n -2-pyridil-n-2-hydroxycarbonylethyl)-amid, ihre herstellung und ihre verwendung als arzneimittel
ATE264315T1 (de) Aminothiazolderivate und ihre verwendung als crf- rezeptor-liganden

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties